Endurant Capital Management as of Sept. 30, 2021
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 53 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 16.8 | $74M | 25k | 2917.47 | |
| Invacare Corp Note 5.000%11/1 (Principal) | 11.7 | $51M | 57M | 0.90 | |
| Trillium Therapeutics Com New Call Option | 8.3 | $36M | 207k | 175.60 | |
| Abbvie (ABBV) | 4.4 | $20M | 180k | 107.87 | |
| Humana (HUM) | 3.9 | $17M | 44k | 389.15 | |
| Johnson & Johnson (JNJ) | 3.6 | $16M | 98k | 161.50 | |
| Hologic (HOLX) | 3.4 | $15M | 200k | 73.81 | |
| Bio Rad Labs Cl A (BIO) | 3.1 | $14M | 18k | 745.95 | |
| Bristol Myers Squibb (BMY) | 2.9 | $13M | 212k | 59.17 | |
| Icon SHS (ICLR) | 2.8 | $12M | 47k | 262.03 | |
| Tenet Healthcare Corp Com New (THC) | 2.7 | $12M | 179k | 66.44 | |
| Si-bone (SIBN) | 2.3 | $10M | 471k | 21.42 | |
| Syneos Health Cl A | 1.8 | $8.1M | 93k | 87.48 | |
| Veracyte (VCYT) | 1.8 | $7.8M | 168k | 46.45 | |
| Cigna Corp (CI) | 1.6 | $7.2M | 36k | 200.15 | |
| Aziyo Biologics Com Cl A (ELUT) | 1.5 | $6.6M | 953k | 6.95 | |
| Avantor (AVTR) | 1.5 | $6.6M | 162k | 40.90 | |
| McKesson Corporation (MCK) | 1.5 | $6.5M | 33k | 199.38 | |
| Owens & Minor (OMI) | 1.5 | $6.4M | 204k | 31.29 | |
| R1 Rcm | 1.4 | $6.2M | 283k | 22.01 | |
| Invacare Corp Note 5.000%11/1 (Principal) | 1.4 | $6.2M | 7.0M | 0.89 | |
| Aptar (ATR) | 1.4 | $6.1M | 51k | 119.36 | |
| Ocular Therapeutix (OCUL) | 1.4 | $6.1M | 610k | 10.00 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 1.2 | $5.3M | 19k | 281.43 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.1 | $4.7M | 918k | 5.17 | |
| Adapthealth Corp Common Stock (AHCO) | 1.0 | $4.5M | 195k | 23.29 | |
| Insmed Com Par $.01 (INSM) | 1.0 | $4.4M | 160k | 27.54 | |
| Selecta Biosciences (RNAC) | 1.0 | $4.2M | 1.0M | 4.16 | |
| Molecular Templates | 0.9 | $4.1M | 614k | 6.71 | |
| Albireo Pharma | 0.8 | $3.7M | 117k | 31.20 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.8 | $3.5M | 1.1M | 3.11 | |
| Dentsply Sirona (XRAY) | 0.8 | $3.5M | 61k | 58.05 | |
| PerkinElmer (RVTY) | 0.8 | $3.3M | 19k | 173.28 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $3.2M | 131k | 24.66 | |
| Praxis Precision Medicines I | 0.6 | $2.8M | 154k | 18.49 | |
| Becton, Dickinson and (BDX) | 0.6 | $2.7M | 11k | 245.82 | |
| Sanofi Sponsored Adr (SNY) | 0.6 | $2.6M | 55k | 48.21 | |
| AmerisourceBergen (COR) | 0.6 | $2.6M | 21k | 119.46 | |
| Regulus Therapeutics Com New | 0.6 | $2.5M | 3.5M | 0.69 | |
| Bellus Health Com New | 0.5 | $2.4M | 390k | 6.14 | |
| Dariohealth Corp Com New (DRIO) | 0.5 | $2.0M | 150k | 13.65 | |
| Mereo Biopharma Group Ads (MREO) | 0.4 | $1.8M | 747k | 2.42 | |
| Axsome Therapeutics (AXSM) | 0.4 | $1.7M | 52k | 32.97 | |
| Immunic (IMUX) | 0.4 | $1.6M | 185k | 8.85 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.3 | $1.5M | 30k | 49.06 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $1.2M | 67k | 17.99 | |
| Krystal Biotech (KRYS) | 0.3 | $1.2M | 23k | 52.23 | |
| Bolt Biotherapeutics (BOLT) | 0.3 | $1.1M | 90k | 12.65 | |
| Allovir (ALVR) | 0.3 | $1.1M | 44k | 25.05 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $959k | 63k | 15.28 | |
| Patterson Companies (PDCO) | 0.2 | $808k | 27k | 30.15 | |
| Celyad Oncology Sa Adr | 0.1 | $596k | 145k | 4.10 | |
| Invacare Corporation | 0.1 | $323k | 1.1M | 0.28 |
